Okulabilira Abalwadde ba kkookolo. Akatabo K'Abajjanjabi.
Provides similar information to patient booklet, Advises on what to expect and how to cope when a loved one is facing end of life Suggests ways for caregivers to take care for themselves
This document contains summary information on the latest projections from the IHME model on COVID-19 in Peru. The model was run on July 15, 2022, with data through July 10, 2022.
Рассматриваются факторы, оказывающие влияние на процесс медикосоциальной реабилитации больных с пограничными психическими расстройствами в современном социуме..., подходы к реабилитации психического здоровья населения. Приводятся результаты авторского исследования медикосоциальных аспектов реабилитации больных с пограничными психическими расстройствами, направленной на коррекцию показателей качества жизни, величину которых определяют нарушения психического состояния и социализации пациента. В исследовании доказывается, что приоритетные направления медикосоциальной реабилитации у данной категории больных определяются возникающими вследствие заболевания изменениями в психологической сфере, социальных отношениях и окружающей среде.
http://www.ssmj.ru/system/files/201102_453-456.pdf
more
This infographic contains information about external contamination, internal contamination and radiation exposure.
Una guía práctica para la prescripción de medicamentos - Muestra cómo la prescripción de un medicamento es un proceso que implica muchas consideraciones, qué principios rigen la elección de un medicamento y cómo construir gradualmente una lista de medicamentos preferidos, productos con los q...ue uno se ha familiarizado plenamente para su uso en la práctica diaria. Se dan ejemplos de cómo seleccionar y prescribir medicamentos, garantizar su cumplimiento y comunicarse eficazmente con los pacientes. Por último, se examinan las distintas fuentes de información farmacéutica, describiendo sus cualidades y deficiencias.
more
Global fund to end Tuberculosis
The article "The Rising Burden of Non-Communicable Diseases in the Americas and the Impact of Population Aging" examines how the aging population in the Americas is contributing to the growing burden of non-communicable diseases (NCDs), despite improvements in disease prevention and health care. Usi...ng data from the World Health Organization and the United Nations, the study analyzes trends in population growth, aging, and NCD-related mortality and disability rates from 2000 to 2019 across 33 countries.
more
PERC has developed a dashboard on Tableau to visualize multidisciplinary data and guide decision-makers on their country’s current performance of the COVID-19 response.
Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing.
This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Chi...ldhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders.
Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries.
Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma.
more
Accessed: 01.05.2020
Breastmilk is the best source of nutrition for infants, including infants whose mothers have confirmed or suspected coronavirus infection. As long as an infected mother takes appropriate precautions—outlined below—she can breastfeed her baby. Breastmilk contains antibodie...s and other immunological benefits that can help protect against respiratory diseases. A growing body of evidence supports the importance of breastfeeding for a child’s growth, development, and health, as well as for helping them avoid obesity and noncommunicable diseases later in life.
more
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...e equipment (PPE) for specimen collection;
addressing chemical hazards and their safe disposal; and
the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
more